RNA polymerase — Drug Target

All drugs that target RNA polymerase — marketed and clinical-stage. Includes 3 drug classes acting on this target.

Drug classes

Rifamycin antibiotic · Nucleoside analog · Antibiotic

Phase 3 pipeline (3)

• open-label rifaximin · Bausch Health Americas, Inc. · Rifamycin antibiotic · Gastroenterology
  Rifaximin works by inhibiting bacterial RNA synthesis, thereby reducing bacterial load in the gut.
• RBV(48 weeks) · Tanabe Pharma Corporation · Nucleoside analog · Infectious Diseases
  Ribavirin is an antiviral medication that works by inhibiting viral RNA synthesis.
• ribavirin with adaptation dose · Hospices Civils de Lyon · Nucleoside analog · Infectious Diseases
  Ribavirin is an antiviral medication that works by inhibiting viral RNA synthesis.

Phase 2 pipeline (1)

• Low Dose Rifaximin DER · Bausch Health Americas, Inc. · Antibiotic · Infectious Disease
  Inhibits bacterial RNA synthesis